BioNTech
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · Germany · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
An Der Goldgrube 12, Mainz, Rheinland-Pf...Phone Number
+49 613190840Website
www.biontech.comRevenue
$3.3 BillionStock Symbol
BNTXIndustry
ZI Rank: 25
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
29
18
16
33
27
25
About BioNTech
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseasesExplore more
BioNTech Org Chart
JS
Operations & Compliance Senior Director, Qual...
FB
Senior Director, Global Regulatory Affairs
AG
Senior Director, Legal
VL
Senior Director, Intellectual Property, Litig...
ML
Global Senior Director, Regulatory Affairs De...
EH
Director, Intellectual Property
GT
Dispute Resolution Director, Legal
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioNTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if BioNTech has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BioNTech launches new products
Congratulate Masked Content for being promoted to Masked Content at BioNTech
Funding: Get notified immidiatlly once BioNTech has new funding data
Check out if BioNTech is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioNTech had a recent Job posting/layoffs
Earning: See what the market has to say on BioNTech recently announced quarterly report
BioNTech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
BioNTech is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
BioNTech is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about BioNTech.
BioNTech financials insights
Gather financial insights about BioNTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$270M
2019
Series B
$325M
Other Financing Round
$55.7M
2020
Multiple Rounds
$694.8M
BioNTech Tech Stack
A closer look at the technologies used by BioNTech
See more technologies
Most Recent Scoops
Person-Based
Medical Research
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Research & Development, Bioengineering, Manufacturing Operations
Person-Based
Research & Development, Manufacturing Operations
BioNTech News & Media
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
MAINZ, Germany, July 21, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August 4, 2026. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. ET (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.Cathie Wood's Ark Invest Sold $7.4 Million of BioNTech Stock
Cathie Wood's biotech ETF has largely moved on from the vaccine maker.BioNTech Shifts Gears: Vaccine Factory Shutdown and Founder Spin-Off Fuel an Oncology ...
BioNTech Shifts Gears: Vaccine Factory Shutdown and Founder Spin-Off Fuel an Oncology-Focused Strategy () | aktiencheck.deBioNTech Faces Shareholder Revolt Over Spin-Off Even as It Prepares First US Cancer Filing ()
BioNTech Faces Shareholder Revolt Over Spin-Off Even as It Prepares First US Cancer Filing () | aktiencheck.de
Read more news
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioNTech
Sign Up For FreeTo access detailed company insights
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases... Read More
